For research use only. Not for therapeutic Use.
Mepyramine maleate is a histamine H1 receptor antagonist and binds with high affinity to G(q/11) protein. Mepyramine maleate is found to be a potent inhibitor of CYP2D6 in hepatocytes. Mepyramine maleate is commonly utilized as a radioligand binding assay for the H1 receptor. This product has been recently discovered to exhibit blocking ability of KCNQ/M channels which is potentially related to an adverse effect seen in excess intake of antihistamines.
| CAS Number | 59-33-6 |
| Synonyms | N1-[(4-Methoxyphenyl)methyl]-N2,N2-dimethyl-N1-2-pyridinyl-1,2-ethanediamine (2Z)-2-Butenedioate; N-[(4-Methoxyphenyl)methyl]-N’,N’-dimethyl-N-2-pyridinyl-?1,2-ethanediamine (2Z)-2-Butenedioate; Bimaleate; AH; Anisopyradamine; Diaminide Maleate; Mepy |
| Molecular Formula | C21H27N3O5 |
| Purity | ≥95% |
| Target | Neuronal Signaling |
| Solubility | Soluble to 10 mM in sterile water |
| Storage | Store at RT |
| IUPAC Name | (Z)-but-2-enedioic acid;N/'-[(4-methoxyphenyl)methyl]-N,N-dimethyl-N/'-pyridin-2-ylethane-1,2-diamine |
| InChI | InChI=1S/C17H23N3O.C4H4O4/c1-19(2)12-13-20(17-6-4-5-11-18-17)14-15-7-9-16(21-3)10-8-15;5-3(6)1-2-4(7)8/h4-11H,12-14H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;2-1- |
| InChIKey | JXYWFNAQESKDNC-BTJKTKAUSA-N |
| SMILES | CN(C)CCN(CC1=CC=C(C=C1)OC)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O |
| Reference | </br>1: Cingi C, Ural K, Acar A, Uzlu E. Efficacy of mepyramine maleate treatment in</br> dogs with angioedema. Pol J Vet Sci. 2010;13(3):549-50. PubMed PMID: 21033572.</br>2: Duke HN. The pulmonary pressor response to hypoxia in isolated perfused lungs </br> of cats: the influence of mepyramine maleate and semicarbazide. J Physiol. 1969</br> Feb;200(2):133P+. PubMed PMID: 4388120.</br>3: [Mepyramine (maleate)]. Ann Pharm Fr. 1961 Jun;19:462-3. French. PubMed PMID: </br> 14447931.</br>4: GOSWAMI R, DAS PC, PHUKAN D. Local anesthetic action of antihistaminics</br> (promethazine hydrochloride and mepyramine maleate). Indian J Med Sci. 1958</br> Feb;12(2):63-71. PubMed PMID: 13524915.</br>5: HOWAT HT, SCHOFIELD B. The effect of urogastrone, enterogastrone and</br> mepyramine maleate on gastric and pancreatic secretion. J Physiol. 1954</br> Jan;123(1):1-15. PubMed PMID: 13131242; PubMed Central PMCID: PMC1366150.</br>6: BAIN WA, BROADBENT JL, WARIN RP. Comparison of anthisan (mepyramine maleate)</br> and phenergan as histamine antagonists. Lancet. 1949 Jul 9;2(6567):47-52. PubMed </br> PMID: 18133887.</br>7: Pillai AG, Awadhiya RP, Vegad JL. Suppression by mepyramine maleate of the</br> increased vascular permeability in passive cutaneous anaphylaxis in the chicken. </br> Vet Res Commun. 1988;12(2-3):161-3. PubMed PMID: 3188384.</br>8: el-Gizawy SM, Ahmed Ael H. High-performance liquid chromatographic</br> determination of mepyramine maleate, pheniramine maleate and phenylpropanolamine </br> hydrochloride in tablets and drops. Analyst. 1987 Jun;112(6):867-9. PubMed PMID: </br> 3619056.</br>9: Tarayre JP, Aliaga M, Villanova G, Barbara M, Bru M, Caillol V, Lauressergues </br> H. [Comparative antiallergic and anti-inflammatory action of F1865, mepyramine</br> maleate, desonide and disodium cromoglycate after cutaneous administration]. J</br> Pharmacol. 1984 Jan-Mar;15(1):37-51. French. PubMed PMID: 6425568.</br>10: Al-Haboubi HA, Zeitlin IJ. The actions of cimetidine hydrochloride and</br> mepyramine maleate in rat adjuvant arthritis. Eur J Pharmacol. 1982 Feb</br> 26;78(2):175-85. PubMed PMID: 7075670.</br>11: Gopalan S, Nayar CK. A comparative study on the antihistaminic potencies of</br> promethazine hydrochloride, mepyramine maleate and pheniramine maleate in dogs.</br> Indian Vet J. 1971 Mar;48(3):295-301. PubMed PMID: 4397014.</br>12: Vegad JL. Effect of hyaluronidase & nucleosides on vascular permeability in</br> sheep & its suppression by mepyramine maleate. Indian J Exp Biol. 1970</br> Apr;8(2):141-2. PubMed PMID: 4097041.</br></br> |
